DeepMed Research

British Columbia Cancer Agency

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA

Phase 2

Recruiting

Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Interventions: Drug: Enzalutamide
Drug: Docetaxel

First Posted Date: 2019-07-11

Last Posted Date: 2024-11-29

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 100

Registration Number: NCT04015622

Locations: 🇨🇦
BC Cancer - Centre for the North, Prince George, British Columbia, Canada
🇨🇦
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre), Kelowna, British Columbia, Canada
🇨🇦
BC Cancer - Surrey Centre, Surrey, British Columbia, Canada

and more 4 locations

Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers

Phase 2

Conditions: Lung Cancer

Interventions: Drug: Omega 3 fatty acid

First Posted Date: 2019-05-03

Last Posted Date: 2019-05-07

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 42

Registration Number: NCT03936621

Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer Female
Hormone Receptor Positive Tumor

Interventions: Drug: Tamoxifen Citrate

First Posted Date: 2019-04-16

Last Posted Date: 2023-06-15

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 290

Registration Number: NCT03917082

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Not Applicable

Recruiting

Conditions: Metastatic Tumors

Interventions: Radiation: palliative radiotherapy
Radiation: Stereotactic ablative radiotherapy

First Posted Date: 2019-03-05

Last Posted Date: 2024-07-29

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 330

Registration Number: NCT03862911

Locations: 🇨🇦
BC Cancer - Prince George, Prince George, British Columbia, Canada
🇦🇺
Cancer Care Griffith, Griffith, New South Wales, Australia
🇦🇺
Riverina Cancer Care Centre, Wagga Wagga, New South Wales, Australia

and more 11 locations

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: LDR Brachytherapy and External Beam Radiation Therapy

First Posted Date: 2019-02-11

Last Posted Date: 2023-02-09

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 105

Registration Number: NCT03836196

Locations: 🇨🇦
BC Cancer - Vancouver, Vancouver, British Columbia, Canada

Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers

Not Applicable

Conditions: Breast Cancer

Interventions: Diagnostic Test: Intervention 1
Diagnostic Test: Intervention 2

First Posted Date: 2019-01-02

Last Posted Date: 2019-01-02

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 50

Registration Number: NCT03790813

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

Phase 2

Active, not recruiting

Conditions: Lung Cancer Non-small Cell Stage IV
Brain Metastases

Interventions: Drug: Osimertinib
Radiation: Stereotactic radiotherapy

First Posted Date: 2018-12-07

Last Posted Date: 2024-10-31

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 40

Registration Number: NCT03769103

Locations: 🇨🇦
BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Not Applicable

Recruiting

Conditions: Pathologic Processes
Neoplasms
Neoplastic Processes
Neoplasm Metastasis

Interventions: Radiation: SUPR
Radiation: VMAT

First Posted Date: 2018-10-03

Last Posted Date: 2024-07-29

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 250

Registration Number: NCT03694015

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

and more 1 locations

MSG Use With 18F-DCFPyL PET/CT Imaging

Not Applicable

Completed

Conditions: Prostate Cancer
Prostate Cancer Metastatic
Prostatic Neoplasm

Interventions: Diagnostic Test: 18F-DCFPyL PET/CT scan
Other: MSG drink
Other: Placebo drink

First Posted Date: 2018-10-03

Last Posted Date: 2023-02-21

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 10

Registration Number: NCT03693742

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

US-CT Fusion for Post Implant Dosimetry

Completed

Conditions: Prostate Cancer

First Posted Date: 2018-10-02

Last Posted Date: 2020-01-27

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 25

Registration Number: NCT03692104

Locations: 🇨🇦
BC Cancer, Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy